These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35602506)

  • 1. Genotype-Phenotype Correlations for Pathogenic
    Savige J; Huang M; Croos Dabrera MS; Shukla K; Gibson J
    Front Med (Lausanne); 2022; 9():865034. PubMed ID: 35602506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.
    Gibson JT; Huang M; Shenelli Croos Dabrera M; Shukla K; Rothe H; Hilbert P; Deltas C; Storey H; Lipska-Ziętkiewicz BS; Chan MMY; Sadeghi-Alavijeh O; Gale DP; ; Cerkauskaite A; Savige J
    Sci Rep; 2022 Feb; 12(1):2722. PubMed ID: 35177655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous Pathogenic
    Savige J
    Kidney Int Rep; 2022 Sep; 7(9):1933-1938. PubMed ID: 36090501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digenic Alport Syndrome.
    Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
    Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 27 Novel Variants in Genes
    Cerkauskaite A; Savige J; Janonyte K; Jeremiciute I; Miglinas M; Kazenaite E; Laurinavicius A; Strupaite-Sileikiene R; Vainutiene V; Burnyte B; Jankauskiene A; Rolfs A; Bauer P; Schröder S; Cerkauskiene R
    Front Med (Lausanne); 2022; 9():859521. PubMed ID: 35419377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic study of Alport syndrome in Tunisia.
    Younsi ME; Achour A; Kraoua L; Nesrine M; Sayari T; Abderrahim E; Laabidi J; Zouaghi MK; Kharrat M; Gargah T; Trabelsi M; M'rad R
    Pediatr Nephrol; 2025 Jan; 40(1):103-116. PubMed ID: 39138691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
    Savige J; Harraka P
    Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hematuria: A review.
    Plevová P; Gut J; Janda J
    Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence Estimates of Predicted Pathogenic
    Gibson J; Fieldhouse R; Chan MMY; Sadeghi-Alavijeh O; Burnett L; Izzi V; Persikov AV; Gale DP; Storey H; Savige J;
    J Am Soc Nephrol; 2021 Sep; 32(9):2273-2290. PubMed ID: 34400539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Pathogenic
    Gibson JT; de Gooyer M; Huang M; Savige J
    Kidney Int Rep; 2022 Nov; 7(11):2454-2461. PubMed ID: 36531881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome.
    Liang L; Wu H; Cai Z; Zhao J
    BMC Med Genomics; 2023 Aug; 16(1):192. PubMed ID: 37596645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alport Syndrome: Clinical Spectrum and Therapeutic Advances.
    Gregorio V; Caparali EB; Shojaei A; Ricardo S; Barua M
    Kidney Med; 2023 May; 5(5):100631. PubMed ID: 37122389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic Case of Heterozygous X-Linked Alport Syndrome.
    Zuckerman JE; Srivastava R
    Glomerular Dis; 2023; 3(1):126-131. PubMed ID: 37901703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study.
    Uliana V; Sebastio P; Riva M; Carli D; Ruberto C; Bianchi L; Graziano C; Capelli I; Faletra F; Pillon R; Mattina T; Sensi A; Bonatti F; Percesepe A
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1576. PubMed ID: 33369211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics and minigene assay of new splicing variant c.4298-20T>A of
    Liang L; Wu H; Cai Z; Zhao J
    Front Genet; 2023; 14():1059322. PubMed ID: 36923787
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel and Founder Pathogenic Variants in X-Linked Alport Syndrome Families in Greece.
    Hadjipanagi D; Papagregoriou G; Koutsofti C; Polydorou C; Alivanis P; Andrikos A; Christodoulidou S; Dardamanis M; Diamantopoulos AA; Fountoglou A; Frangou E; Georgaki E; Giannikouris I; Gkinis V; Goudas PC; Kalaitzidis RG; Kaperonis N; Koutroumpas G; Makrydimas G; Myserlis G; Mitsioni A; Paliouras C; Papachristou F; Papadopoulou D; Papagalanis N; Papagianni A; Perysinaki G; Siomou E; Sombolos K; Tzanakis I; Vergoulas GV; Printza N; Deltas C
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553470
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.